Can pressurised intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-O+) be added to standard treatment for resectable high-risk gastric cancer patients? A study protocol

OBJECTIVES: Gastric cancer remains one of the most fatal cancers, despite an intensive treatment regime of chemotherapy–surgery–chemotherapy. Peritoneal metastatic disease is commonly diagnosed post treatment regime and once established, patients are likely to die in 3–9 months. Systemic chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Reid, Jessica L., Kanhere, Harsh A., Hewett, Peter J., Price, Timothy J., Maddern, Guy J., Trochsler, Markus I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722176/
https://www.ncbi.nlm.nih.gov/pubmed/35071735
http://dx.doi.org/10.1515/pp-2021-0132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722176/
https://www.ncbi.nlm.nih.gov/pubmed/35071735
http://dx.doi.org/10.1515/pp-2021-0132

Ejemplares similares